Kim Hyeong Geug, Cho Jung-Hyo, Kim Jeongkyu, Kim Seung-Jin
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, United States.
Department of East & West Cancer Center, Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, South Korea.
Front Physiol. 2021 Jul 16;12:691738. doi: 10.3389/fphys.2021.691738. eCollection 2021.
Alcoholic steatohepatitis (ASH) is a progression hepatitis with severe fatty liver and its mortality rate for 30-days in patients are over 30%. Additionally, ASH is well known for one-fifth all alcoholic related liver diseases in the world. Excessive chronic alcohol consumption is one of the most common causes of the progression of ASH and is associated with poor prognosis and liver failure. Alcohol abuse dysregulates the lipid homeostasis and causes oxidative stress and inflammation in the liver. Consequently, metabolic pathways stimulating hepatic accumulation of excessive lipid droplets are induced. Recently, many studies have indicated a link between ASH and epigenetic changes, showing differential expression of alcohol-induced epigenetic genes in the liver. However, the specific mechanisms underlying the pathogenesis of ASH remain elusive. Thus, we here summarize the current knowledge about the roles of epigenetics in lipogenesis, inflammation, and apoptosis in the context of ASH pathophysiology. Especially, we highlight the latest findings on the roles of Sirtuins, a conserved family of class-III histone deacetylases, in ASH. Additionally, we discuss the involvement of DNA methylation, histone modifications, and miRNAs in ASH as well as the ongoing efforts for the clinical translation of the findings in ASH-related epigenetic changes.
酒精性脂肪性肝炎(ASH)是一种伴有严重脂肪肝的进行性肝炎,患者30天死亡率超过30%。此外,ASH是全球五分之一酒精相关性肝病的常见病因。长期过量饮酒是ASH病情进展的最常见原因之一,与预后不良和肝衰竭相关。酒精滥用会破坏脂质稳态,导致肝脏氧化应激和炎症。因此,会诱导刺激肝脏中过量脂质小滴积累的代谢途径。最近,许多研究表明ASH与表观遗传变化之间存在联系,显示酒精诱导的表观遗传基因在肝脏中存在差异表达。然而,ASH发病机制的具体机制仍不清楚。因此,我们在此总结当前关于表观遗传学在ASH病理生理学背景下在脂肪生成、炎症和细胞凋亡中的作用的知识。特别是,我们重点介绍了Ⅲ类组蛋白去乙酰化酶的保守家族——沉默调节蛋白在ASH中的作用的最新发现。此外,我们还讨论了DNA甲基化、组蛋白修饰和微小RNA在ASH中的作用,以及将ASH相关表观遗传变化的研究成果转化为临床应用的正在进行的努力。